SK

Santhosh Kulkarni

Director Director DIN 03230427
DIN 03230427 First appointment Jul 2006 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2006
Shareholding value Locked Premium profile

About Santhosh Kulkarni

Data last updated:

Santhosh Kulkarni has 20 years in corporate governance. Formerly with 1 company, such as Cantus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03230427
Primary Designation Director
First Appointment 10 Jul 2006
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director10 Jul 20062006Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cantus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Santhosh Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santhosh Kulkarni

Santhosh Kulkarni has 20 years in corporate governance. Formerly with 1 company, such as Cantus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Santhosh Kulkarni is associated with 0 companies as a director.

Santhosh Kulkarni has expertise in General Business.

Santhosh Kulkarni has 20 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available